Sanofi
A global integrated healthcare leader discovers, develops and distributes therapeutic solutions.
Launch date
Employees
Market cap
€128.8b
Enterprise valuation
€145.8b (Public information from Sep 2024)
Share price
€102.96 SAN.PA
Paris Île-de-France (HQ)
Corporate Venture Fund: Sanofi Ventures
Financials
Estimates*
EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 37.4b | 39.2b | 45.4b | 46.4b | 47.4b | 50.6b | 53.6b |
% growth | (1 %) | 5 % | 16 % | 2 % | 2 % | 7 % | 6 % |
EBITDA | 9.8b | 10.8b | 13.8b | 15.2b | 13.7b | 15.5b | 16.4b |
% EBITDA margin | 26 % | 27 % | 30 % | 33 % | 29 % | 31 % | 31 % |
Profit | 12.3b | 6.2b | 6.7b | 5.4b | 6.8b | 8.8b | 9.8b |
% profit margin | 33 % | 16 % | 15 % | 12 % | 14 % | 17 % | 18 % |
EV / revenue | 2.9x | 3.1x | 2.6x | 2.6x | 2.8x | 2.6x | 2.4x |
EV / EBITDA | 11.0x | 11.3x | 8.7x | 7.9x | 9.9x | 8.5x | 7.7x |
R&D budget | 5.5b | 5.7b | 6.7b | 6.7b | - | - | - |
R&D % of revenue | 15 % | 15 % | 15 % | 14 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
$310m | Post IPO Equity | ||
$30.8m | Grant | ||
$2.0b | Grant | ||
* | $229k | - | |
Total Funding | €1.8b |
Related Content
Recent News about Sanofi
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
By Country
ACQUISITION by Sanofi Jan 2021
ACQUISITION by Sanofi Aug 2020
ACQUISITION by Sanofi Jan 2018
ACQUISITION by Sanofi Apr 2021
ACQUISITION by Sanofi Sep 2021
ACQUISITION by Sanofi Aug 2021